The Anti-Radiation Drugs Market is expanding as governments, defense agencies, oncology centers, and pharmaceutical developers prioritize medical countermeasures that mitigate cellular damage from ionizing radiation. Growth is supported by rising cancer radiotherapy volumes, heightened geopolitical and nuclear safety preparedness, national emergency stockpiling programs, and advancements in...
The Nucleic Acid Amplification Testing (NAAT) Market is expanding as hospitals, diagnostic laboratories, and public health agencies shift toward rapid, high-sensitivity molecular diagnostics for early disease detection and targeted treatment. Growth is supported by rising infectious disease prevalence, expansion of point-of-care (POC) testing platforms, oncology biomarker screening, and...
US Stomach Cancer Market expansion is encouraged by substantial pharmaceutical research activity and clinical trial investments. Research organizations and drug developers are investigating novel treatment candidates to address unmet needs in gastric cancer care.
The stomach cancer market is expected to reach US$ 12,541 million by 2031, registering a CAGR of 14.9% during the forecast period...
Molecular Robotics draws direct inspiration from nature's own nanomachines, such as kinesin, myosin, and ATP synthase. By studying how biological protein motors convert chemical energy into mechanical work inside living cells, scientists engineer synthetic counterparts with tailored capabilities.
The global molecular robotics market size is projected to reach US$ 11.67 billion by 2034 from...
US Small Animal Imaging Market expansion is supported by investments in advanced imaging platforms and laboratory infrastructure. Pharmaceutical companies and contract research organizations are strengthening research capabilities through optical imaging, micro-MRI, micro-CT, and nuclear imaging technologies.
The global small animal imaging market size is projected to reach US$ 2.47 billion by...
North America Lymphoma Treatment Market growth is also supported by the presence of specialized cancer hospitals and established oncology distribution networks. These facilities help deliver complex medicines and coordinate treatment, monitoring, and supportive care for lymphoma patients.
The Lymphoma Treatment Market size is expected to reach US$ 2.67 billion by 2034 from US$ 1.71 billion in...
The Global Genomics Market is experiencing substantial growth as advances in genetic research, sequencing technologies, and molecular diagnostics transform healthcare and life sciences. Genomics involves the study of an organism’s complete DNA, including the interactions and functions of genes. Its applications span disease diagnosis, personalized medicine, drug discovery, agricultural...
The global Oncology Clinical Trials Market is shaped by changing healthcare requirements and the growing demand for innovative cancer treatments. Polaris Market Research has prepared this report to provide an overview of the industry and its expected development over the coming years. It examines the factors influencing market activity and explains how revenue is distributed across different...
Global contrast media API market is gaining attention across the pharmaceutical and healthcare industries as increasing diagnostic imaging procedures and advances in medical imaging technologies drive demand for high-purity active pharmaceutical ingredients. Contrast media APIs are essential chemical substances used in injectable formulations to improve the visibility of internal body...
The HDAC Inhibitor Market is gaining attention as pharmaceutical companies increasingly explore epigenetic therapies for cancer and other complex diseases. Histone deacetylase inhibitors regulate gene expression by blocking HDAC enzymes, influencing cellular processes such as differentiation, proliferation, and apoptosis. Their therapeutic potential is supporting continued research and...
The North America Intensity Modulated Radiotherapy Market holds a leading position due to its advanced healthcare infrastructure and established radiation oncology services. The region benefits from the availability of modern treatment equipment, specialized cancer centers, and experienced clinical professionals.
The Intensity Modulated Radiotherapy Market was valued at US$ 2.56 billion in 2025...
The global High Content Screening Market is experiencing significant growth as pharmaceutical companies, biotechnology organizations, and research institutions increasingly focus on advanced drug discovery and cellular analysis technologies. The market was valued at US$ 764.40 million in 2025 and is projected to reach US$ 1,642.20 million by 2034, registering a compound annual growth rate of...